恩替卡韦治疗慢性乙型肝炎合并肺结核的疗效分析_第1页
恩替卡韦治疗慢性乙型肝炎合并肺结核的疗效分析_第2页
恩替卡韦治疗慢性乙型肝炎合并肺结核的疗效分析_第3页
恩替卡韦治疗慢性乙型肝炎合并肺结核的疗效分析_第4页
全文预览已结束

下载本文档

版权说明:本文档由用户提供并上传,收益归属内容提供方,若内容存在侵权,请进行举报或认领

文档简介

-精选财经经济类资料- -最新财经经济资料-感谢阅读- 1 恩替卡韦治疗慢性乙型肝炎合并肺 结核的疗效分析 关键词 慢性乙型肝炎;肺结核;恩 替卡韦;肝功能 中图分类号 R512.62 文献标识 码 B 文章编号 1673-9701(2017)14- 0097-03 Abstract Objective To observe the clinical efficacy of the application of entecavir in the treatment of chronic hepatitis B complicated with pulmonary tuberculosis. Methods A total of 62 patients with chronic hepatitis B complicated with pulmonary tuberculosis were collected as the research subjects. They were diagnosed from January 2014 -精选财经经济类资料- -最新财经经济资料-感谢阅读- 2 to July 2016. They were randomly assigned to the observation group and the control group, with 31 patients in each group. Both groups were given the same initial treatment protocol of anti- tuberculosis. In addition, the observation group was given entecavir tablets. The liver function indices and HBV-DNA level between two groups were compared before and after the treatment. Results Liver function indices: ALB, ALT and TBIL levels were significantly decreased in both groups after the treatment, and the differences were statistically significant compared with those before the treatment (P0.05). ALB, ALT and TBIL levels in the observation group after the treatment were even lower than those in the control group, and the differences between the two groups were statistically significant(P0.05). HBV-DNA -精选财经经济类资料- -最新财经经济资料-感谢阅读- 3 level: HBV-DNA level in both groups after the treatment was significantly decreased, and the difference was statistically significant compared with that before the treatment (P0.05). HBV- DNA level in the observation group after the treatment was even lower than that in the control group, and the difference between the two groups was statistically significant (P0.05). Conclusion Entecavir has a significant improving effect on the liver function in the patients with chronic hepatitis B complicated with pulmonary tuberculosis, which can greatly inhibit the replication of virus. It is suggested that the application of entecavir be popularized in the patients with chronic hepatitis B complicated with pulmonary tuberculosis. Ke

温馨提示

  • 1. 本站所有资源如无特殊说明,都需要本地电脑安装OFFICE2007和PDF阅读器。图纸软件为CAD,CAXA,PROE,UG,SolidWorks等.压缩文件请下载最新的WinRAR软件解压。
  • 2. 本站的文档不包含任何第三方提供的附件图纸等,如果需要附件,请联系上传者。文件的所有权益归上传用户所有。
  • 3. 本站RAR压缩包中若带图纸,网页内容里面会有图纸预览,若没有图纸预览就没有图纸。
  • 4. 未经权益所有人同意不得将文件中的内容挪作商业或盈利用途。
  • 5. 人人文库网仅提供信息存储空间,仅对用户上传内容的表现方式做保护处理,对用户上传分享的文档内容本身不做任何修改或编辑,并不能对任何下载内容负责。
  • 6. 下载文件中如有侵权或不适当内容,请与我们联系,我们立即纠正。
  • 7. 本站不保证下载资源的准确性、安全性和完整性, 同时也不承担用户因使用这些下载资源对自己和他人造成任何形式的伤害或损失。

评论

0/150

提交评论